Evidence map›Paper›PMID 8972179›Full record

ArticleMolecular and cellular biology1997

The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression.

C Kannabiran, X Zeng, L D Vales

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Modulation of NF-κB-dependent gene transcription using programmable DNA minor groove binders.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C KannabiranDepartment of Biochemistry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway 08854-5635, USA.
X Zeng
L D Vales

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cellular interleukin-6 (IL-6) gene contains a target site for the mammalian transcriptional repressor RBP. The target site is contained within the interleukin response element (ILRE), which mediates IL-6 activation by NF-kappa B. In this study, we show by using transient-expression assays that RBP represses activated transcription from the IL-6 gene. The presence and position of the RBP target site are crucial in mediating repression by RBP. While RBP binds within the ILRE, it does not target NF-kappa B alone; nonetheless, NF-kappa B binding to the ILRE is required for repression. Our results indicate that RBP represses coactivation by NF-kappa B and another cellular transcription factor, C/EBP-beta.

Indexed as

3T3 CellsAnimalsBinding SitesCCAAT-Enhancer-Binding ProteinsCell LineCOS CellsDNA-Binding ProteinsGene Expression RegulationImmunoglobulin J Recombination Signal Sequence-Binding ProteinInterleukin-6InterleukinsMiceMutationNF-kappa BNuclear ProteinsPromoter Regions, GeneticCCAAT-Enhancer-Binding ProteinsDNA-Binding ProteinsImmunoglobulin J Recombination Signal Sequence-Binding ProteinInterleukin-6InterleukinsNF-kappa BNuclear ProteinsRbpj protein, mouseRepressor ProteinsRNA, MessengerTranscription Factor RelA

Identifiers

PMID8972179
PMCPMC231723
OpenAlexW1856176769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.